Is Titan Pharmaceuticals, Inc. common stock (TTNP) Stock Worth a Buy Friday?

Friday, February 10, 2023 02:03 PM | InvestorsObserver Analysts

Mentioned in this article

Is Titan Pharmaceuticals, Inc. common stock (TTNP) Stock Worth a Buy Friday?

Titan Pharmaceuticals, Inc. common stock (TTNP) stock is lower by -19.33% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives TTNP stock a score of 26 out of a possible 100.

That rank is chiefly influenced by a long-term technical score of 27. TTNP's rank also includes a short-term technical score of 51.

TTNP has an Overall Score of 26. Find out what this means to you and get the rest of the rankings on TTNP!

See Full TTNP Report

What's Happening with TTNP Stock Today

Titan Pharmaceuticals, Inc. common stock (TTNP) stock is up 3.24% while the S&P 500 is lower by -0.09% as of 1:49 PM on Friday, Feb 10. TTNP has gained $0.03 from the previous closing price of $0.93 on volume of 12,188 shares. Over the past year the S&P 500 is lower by -9.46% while TTNP is lower by -19.33%. TTNP lost -$0.85 per share in the over the last 12 months. Click Here to get the full Stock Report for Titan Pharmaceuticals, Inc. common stock stock.